NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 0.5 mM [U-15N] human FK506 binding protein 25 (hFKBP25)-7, 10 % [U-100% 2H] D2O-8, 90 % H2O-9, 50 mM sodium chloride-10, 20 mM sodium phosphate-11, 0.001 % sodium azide-12 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
2 | 3D HNCA | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
3 | 3D HN(CO)CA | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
4 | 3D HNCACB | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
5 | 3D CBCA(CO)NH | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
6 | 3D HNCO | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
7 | 3D HN(CA)CO | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
8 | 3D C(CO)NH | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
9 | 3D H(CCO)NH | 0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-6 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
10 | 3D HNHA | 0.5 mM [U-15N] human FK506 binding protein 25 (hFKBP25)-7, 10 % [U-100% 2H] D2O-8, 90 % H2O-9, 50 mM sodium chloride-10, 20 mM sodium phosphate-11, 0.001 % sodium azide-12 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |
11 | 3D HCCH-TOCSY | 0.5 mM [U-13C] human FK506 binding protein 25 (hFKBP25)-13, 100 % [U-100% 2H] D2O-14, 50 mM sodium chloride-15, 20 mM sodium phosphate-16, 0.001 % sodium phosphate-17 | 100% D2O | 70 | 7 | ambient | 298 | |
12 | 3D 1H-13C NOESY | 0.5 mM [U-13C] human FK506 binding protein 25 (hFKBP25)-13, 100 % [U-100% 2H] D2O-14, 50 mM sodium chloride-15, 20 mM sodium phosphate-16, 0.001 % sodium phosphate-17 | 100% D2O | 70 | 7 | ambient | 298 | |
13 | 3D 1H-15N NOESY | 0.5 mM [U-15N] human FK506 binding protein 25 (hFKBP25)-7, 10 % [U-100% 2H] D2O-8, 90 % H2O-9, 50 mM sodium chloride-10, 20 mM sodium phosphate-11, 0.001 % sodium azide-12 | 90% H2O/10% D2O | 70 | 7 | ambient | 298 | |